Dimensional Fund Advisors
RPTX

Dimensional Fund Advisors’s Repare Therapeutics RPTX Stock Holding History

Dimensional Fund Advisors’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,265
Closed -$13.1K – 3322
2025
Q1 		$13.1K Hold
13,265
– – ﹤0.01% 3312
2024
Q4 		$17.4K Hold
13,265
– – ﹤0.01% 3328
2024
Q3 		$45.6K Hold
13,265
– – ﹤0.01% 3306
2024
Q2 		$43.8K Sell
13,265
-27,504
-67% -$98.1K ﹤0.01% 3324
2024
Q1 		$192K Sell
40,769
-3,298
-7% -$21.1K ﹤0.01% 3193
2023
Q4 		$322K Sell
44,067
-7,168
-14% -$40.1K ﹤0.01% 3117
2023
Q3 		$619K Sell
51,235
-3,607
-7% -$37.2K ﹤0.01% 3019
2023
Q2 		$580K Buy
54,842
+80
+0.1% +$824 ﹤0.01% 3028
2023
Q1 		$539K Buy
54,762
+1,577
+3% +$18.1K ﹤0.01% 3017
2022
Q4 		$783 Buy
53,185
+40,206
+310% +$601K ﹤0.01% 2958
2022
Q3 		$157K Sell
12,979
-28,867
-69% -$372K ﹤0.01% 3276
2022
Q2 		$585K Sell
41,846
-7,965
-16% -$93.8K ﹤0.01% 3031
2022
Q1 		$709K Sell
49,811
-1,625
-3% -$24.1K ﹤0.01% 3074
2021
Q4 		$1.08M Buy
51,436
+12,195
+31% +$287K ﹤0.01% 3014
2021
Q3 		$1.03M Buy
+39,241
New +$1.27M ﹤0.01% 3046

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors's RPTX Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 13,265 shares — an estimated $13.1K sold.

Dimensional Fund Advisors first reported a position in RPTX in Q3 2021 and held it in 15 quarters. The position peaked at $1.08M in Q4 2021. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 13,265 Repare Therapeutics shares in Q2 2025, an estimated $13.1K.
  • Dimensional Fund Advisors first reported a position in Repare Therapeutics in Q3 2021 and held it in 15 quarters.
  • Dimensional Fund Advisors's Repare Therapeutics position peaked at $1.08M in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.